This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Covidien Launches Two Enhanced LigaSure™ Vessel Sealing Products At American College Of Surgeons Clinical Congress 2013

Stocks in this article: COV

Covidien (NYSE: COV), a leading global provider of healthcare products, is strengthening its vessel sealing portfolio with the launch of two advanced energy devices, the LigaSure Impact™ curved large jaw open sealer/divider LF4318 and LigaSure™ blunt tip laparoscopic sealer/divider LF1637. The two products offer improvements in handling, control and performance, as compared to their predecessor devices. LigaSure products used with the ForceTriad™ energy platform utilize TissueFect™ sensing technology, a proprietary Covidien control system designed to precisely manage energy delivery, creating a range of options for desired tissue effect.

“Around the world, Covidien’s LigaSure devices are a trusted and valued product portfolio in the operating room. LigaSure vessel sealing instruments already are used in millions of surgical procedures and we continue to innovate to enhance our products,” said Chris Barry, President of Advanced Surgical Technologies, Covidien. “Since introduction in 1998, our LigaSure devices, combined with TissueFect sensing technology, have set the standard in vessel sealing.”

The LigaSure Impact device, featuring a curved, large jaw open sealer/divider, offers improved visibility in the surgical field, more intuitive jaw positioning and enhanced ergonomics for a better surgical experience. The LigaSure blunt tip laparoscopic sealer/divider has contoured tips for improved dissection, better handling and a more compact, ergonomic handle for greater comfort and control for various hand sizes.

Both the LigaSure Impact and blunt tip devices received U.S Food and Drug Administration 510(k) clearance earlier this year and are ideally suited for colorectal, general, gynecologic, urologic and thoracic surgery.

About LigaSure and TissueFect

With more than eight million procedures completed worldwide, LigaSure technology is supported by an ever-growing body of evidence-based research, now totaling well over 300 published peer-reviewed studies.

LigaSure tissue fusion in the ForceTriad energy platform, has faster fusion cycles, more flexible fusion zones and less desiccation than the original LigaSure generator. TissueFect sensing technology monitors changes in tissue 3,333 times a second and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,590.21 +233.34 1.34%
S&P 500 2,039.82 +26.93 1.34%
NASDAQ 4,703.61 +59.2980 1.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs